Medicinal composition for treating aplastic anemia

摘要

The present invention is a medicament composition for treatment of aplastic anemia which uses romiprost as an active ingredient and is subcutaneously administered once a week and is administered as a romiprost for 4 weeks from the start of administration μ G / kg / week, and after 5 weeks, romiprost μ G / kg / Max μ The present invention relates to a pharmaceutical composition characterized by administration of g / kg / week.